Skip to navigation Skip to content



U.S. Senate Votes to Protect Medical Research Funding

June 9, 2016

On Tuesday, June 7th,  the U.S. Senate protected important, innovative MS research funded by the Congressionally Directed Medical Research Program (CDMRP) — thanks to MS activists!

MS activists’ outreach over the past week increased bipartisan cosponsorship of the amendment and helped achieve this victory. More than 4,390 letters were sent and countless calls were made to Capitol Hill. As Senator McCain said during floor debate, “our phones have been ringing off the hook.”

If your Senator(s) voted for the amendment, please send him/her a thank you message (you can find out how Senators voted here). 

The MS CDMRP received a $1 million increase in FY 2016--for a total of $6 million. In FY 2017, the House Appropriations Committee approved the same $6 million for the MS CDMRP. The Senate Appropriations Committee does not provide specific funding for the MS CDMRP, but has recommended a five percent increase over its 2016 funding level for medical research.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.